AE-QoL - Angioedema Quality of Life Score

Basic description

Developed in 2012

Authors

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

MOXIE Company

For clinical routine, scientific or commercial use or in case a translation / cross cultural adaptation of the AE-QoL is intended, please check the terms and conditions on www.moxie-gmbh.de

Objective

To measure health-related quality of life (HRQoL) impairment in patients with recurrent angioedema

Therapeutic area

Cardiovascular Diseases
Skin and Connective Tissue Diseases
Immune System Diseases

Therapeutic indication

Angioedema
Urticaria

Idiopathic Angioedema, Acquired Angioedema

Type of Clinical Outcome Assessment (COA)

Original language(s)

German for Germany

Translations

28 translation(s)

Bibliographic reference(s) of the original questionnaire

Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012 Oct;67(10):1289-98 (Full Text Article)

Weller K, Magerl M, Peveling-Oberhag A, et al. The Angioedema Quality of Life Questionnaire (AE-QoL) - Assessment of Sensitivity to Change and Minimal Clinically Important Difference. Allergy. 2016 Aug;71(8):1203-9 (PubMed Abstract)

Angioedema Quality of Life Score (AE-QoL)

Basic description

Member Access

YOU MIGHT ALSO BE INTERESTED IN:

MAPI RESEARCH TRUST

Angioedema Quality of Life Score (AE-QoL)

Basic description

Member Access

Already a subscriber

Subscribe to PROQOLID to access to full information

YOU MIGHT ALSO BE INTERESTED IN: